Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Fusion Antibodies Ltd. is a biotechnology company that specializes in antibody engineering services. It is dedicated to supporting pharmaceutical and biopharmaceutical companies in advancing their antibody discovery and development programs. The company's core focus is on providing customized solutions through its comprehensive platform that aids in the design, development, and optimization of monoclonal antibodies. Fusion Antibodies Ltd. impacts industries such as healthcare, pharmaceuticals, and biotechnology by contributing to the discovery of therapeutic antibodies, which are fundamental in the development of treatments for a variety of diseases, including cancer and infectious diseases. Headquartered in the United Kingdom, Fusion Antibodies Ltd. plays a significant role in the biotechnology sector, providing essential services in the early phases of drug research and development. By leveraging technological advancements and scientific expertise, it aims to enhance the efficacy, safety, and production of therapeutic antibodies, thereby facilitating the acceleration of drugs from concept to market.